Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance of PET/MRI Versus Standard of Care Imaging (PET/CT and/or CT and/or PET) in Preoperative Women With Presumed Early-stage High Grade Endometrial Carcinoma

NCT05390021 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05390021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05390021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance of PET/MRI Versus Standard of Care Imaging (PET/CT and/or CT and/or PET) in Preoperative Women With Presumed Early-stage High Grade Endometrial Carcinoma
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
March 30, 2024
Completion date
February 1, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cytoreductive surgery, endometrial mixed cell adenocarcinoma, endometrial undifferentiated carcinoma, grade 3 endometrial endometrioid adenocarcinoma, high grade serous carcinoma